ContactLumiMeds Review
LumiMeds publishes its compounded GLP-1 plan prices up front. Semaglutide runs $189 per month on a standard subscription or $133 per month when you prepay three months. Tirzepatide is $279 per month on the monthly plan, $216 per month on a three-month value plan, and also appears in a three-month starter bundle at $133 per month.
Plans bundle the intake consult, access to the clinician team, the prescription when clinically appropriate, medication, and monthly check-ins. Pricing stays fixed even as your dose changes, insurance is not required, and the FAQ highlights HSA and FSA acceptance along with shipping to most states subject to local rules.
About LumiMeds
Clear plan menu and dose-agnostic pricing; best if you can pre-plan refills and you are comfortable with compounded medications and firm policies.
Why it's for you
- Posted GLP-1 prices with several commitment options, from $133 per month on three-month prepays to $189 per month on monthly semaglutide.
- Fixed pricing regardless of dosage removes surprise titration increases.
- Each plan includes intake, clinician support, the prescription if appropriate, medication, and monthly check-ins.
- Insurance is not required, HSA and FSA payments are accepted, and shipping is advertised for most states.
- The site displays a LegitScript certification badge.
Why it's not for you
- Membership terms create a fixed financial obligation for the full plan; there is no early termination once a term starts.
- Terms of Use specify a $60 cancellation fee before pharmacy submission, no refunds after the pharmacy receives the order, and a 28-day advance notice requirement for subscription cancellations.
- LumiMeds selects the dispensing pharmacy, risk of loss passes to the carrier, and shipping issues must be reported within 48 hours.
- Compounded GLP-1 medications are not FDA-approved products.
- The FDA issued a warning letter on September 9, 2025 about LumiMeds’ website marketing claims for compounded GLP-1s, highlighting advertising compliance concerns.
Pricing and plan options
Semaglutide is offered at $189 per month on a standard subscription or $133 per month when you prepay a three-month block. Tirzepatide follows the same format with $279 monthly, $216 per month on the three-month value plan, and a $133 per month three-month starter that totals $399.
What you get is spelled out: the initial consult, real-time clinician support, prescription writing when clinically appropriate, medication, and monthly follow-ups. The homepage reinforces that pricing is fixed regardless of dose, which helps as doses titrate upward.
How it works and timing
You complete the intake online, a clinician reviews your chart (often within about two days), and approved prescriptions route to third-party partner pharmacies for compounding and shipment. Shipping is available to most states where compounded medications are permitted, and eligibility is confirmed during intake.
LumiMeds is not a pharmacy and customers do not choose the pharmacy. The Terms state that risk of loss passes when the carrier accepts the package and any shipping issue must be reported within 48 hours, so build a buffer around refill dates.
Compounded medications explained
The site reiterates that LumiMeds dispenses compounded semaglutide and tirzepatide, which are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. The prescriber ultimately determines whether a compounded product is appropriate for you.
Policies you should read
Membership terms treat each plan as a fixed-term obligation. The Terms of Use outline a $60 cancellation fee unless a clinician declines treatment, bar refunds once the pharmacy receives the order, and require 28-day notice before subscription renewals.
Shipping terms note that LumiMeds selects the pharmacy, risk of loss passes to the carrier, and customers must report issues within 48 hours so the team can review packing footage.
Dispute resolution is handled through binding arbitration with a 30-day opt-out window and a class-action waiver.
Regulatory update: on September 9, 2025 the FDA issued a warning letter citing LumiMeds’ marketing claims for compounded GLP-1s as misleading. Warning letters focus on advertising compliance and do not automatically trigger a product recall, but it is a factor to consider.
Bottom line
Keith Murphy
Senior Editor
LumiMeds is attractive if you want dose-agnostic cash pricing and you are willing to follow firm cancellation and shipping policies. The three-month prepays lower the monthly equivalent and the plan inclusions keep support in one place. Set reminders for renewal windows, keep copies of the Terms and shipping emails, and review the FDA warning letter so you understand the regulatory backdrop before enrolling.
Compare plansReach your goals with the right GLP-1
Choose a provider that fits you and your journey.
Check your pricing
How can we help?
Need a quick answer? Check our knowledge base to see if your question is already answered and find what you need right away.
Go to the knowledge base
Email For questions about GLP-1 programs or feedback about our website.
Send us a message
Prefer to call? Reach us Monday to Friday between 08:30 and 17:30 with any question.
010 - 34 003 21
